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ABSTRACT 
Boron sulfonic acid was applied as an efficient heterogeneous and reusable catalyst for the synthesis of 2H-indazolo[1,2-b] 
phthalazine-trione derivatives. A broad range of aromatic aldehydes were condensed via a one-pot three component reaction with 
phthalhydrazide and dimedone. The process was done under solvent-free conditions. High yields, short reaction times, easy 
work-up, eco-friendly, easy handling, availability and reusability of the catalyst are the main aspects of the present method.   
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INTRODUCTION 
Multi-component reactions (MCRs) play an important role in 
combinatorial chemistry. These reactions are able to synthesize 
target compounds with greater efficiency and atom economy. 
They generate structural complexity in a single operation 
without the isolation of intermediates[1] from three or more 
reactants. Moreover, MCRs offer the advantage of simplicity 
and synthetic efficiency over conventional chemical 
reactions[2]. Heterocyclic compounds containing the 
phthalazine ring are important targets in synthetic and 
medicinal chemistry, because this fragment is a key moiety in 
different pharmacological active compounds[3,4]. Phthalazine 
derivatives were found to possess cytotoxic[5], 
antimicrobial[6], anticonvulsant[7], antifungal[8], 
anticancer[9], and anti-inflammatory[10] activities. 
Phthalazine-containing compounds are also highly potent 
inhibitors of vascular endothelial growth factor receptor II 
(VEGFR-2)[11-13]. Moreover, these compounds exhibited 
good promise as new luminescence materials or fluorescence 
probes[14]. Therefore, it is not surprising that many synthetic 
methods have been developed for this compounds[15-27]. 
However, most of these reported procedures describe synthesis 
of only a narrow range of phthalazines. Furthermore, some of 
these methods suffered with one or more drawbacks such as 
hazardous organic solvents, use of strong acids, long reaction 
time, high costs and harsh reaction conditions with 
non-recyclable catalyst. Thus, the development of a new, 
efficient, and general protocol for the synthesis of heterocycles 
containing phthalazine ring fragment is an active ongoing 
research area, and there is further potential improvement 
toward green chemistry and improved yields.The principles of 
“Green Chemistry” emphasize the usage of environmentally 
benign catalysts and chemicals in order to have minimal 
adverse effects on the environment[28].One of the most 
suitable strategies to design environmentally benign catalytic 
systems is the preparation of solid acid catalysts with strong 
acidic sites. It is obviously deducible from the literature that the 
applications of solid acid catalysts have become more 
prominent in organic transformations, since they have unique 
properties and several advantages[29-31] over traditional 
liquid acids[32], such as facile handling, easy separation of 
products, easy recovery and reusability of the catalyst. In 
combination with the application of heterogeneous solid acids, 
solvent-free reactions promise to be an essential facet of ‘Green 
Chemistry’. Solvent-free reactions have attracted much interest 
because of their ease of experimental procedures and workup, 
low cost and environmentally benign nature[33]. 
The application of boron reagents in organic synthesis led to 
Herbert C. Brown (1912-2004) being awarded the Nobel Prize 
in Chemistry in 1979[34] and since that time this relatively rare 
element has remained on the cutting-edge of modern synthetic 
chemistry. Recently, Kiasat and co-workers[35] have reported 
regioselective conversion of epoxides to thiocyanohydrins 
using Boron sulfonic acid as a new solid acid catalyst, under 
solvent-free conditions. 
Boron sulfonic acid was easily prepared by addition of 
chlorosulfonic acid to boric acid under N2 atmosphere at room 
temperature[35]. This reaction was easy and clean, because 
HCl gas was evolved from the reaction vessel immediately 
(Scheme 1). 
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Scheme 1 Preparation of B(HSO4)3 
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Now, as we continued our studies for developing efficient and 
environmentally benign synthetic protocols[36, 37] we found 
out a highly efficient methodology for the synthesis of 
2H-indazolo[1,2-b]-phthalazine-trione derivatives (4a-n)via a 
one-pot three-component condensation reaction of dimedone 
(1), phthalhydrazide (2) and aromatic aldehydes (3a-n) in the 
presence of catalytic amount of boron sulfonic acid under 
solvent-free conditions (Scheme 2). 
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Entry 3 Ar-CHO Product 
 (4a-n) / Ar-  
1 a Ph-CHO Ph- 
2 b 4-Cl-Ph-CHO 4-Cl-Ph- 
3 c 3-Cl-Ph-CHO 3-Cl-Ph- 
4 d 2,4-Cl2-Ph-CHO 2,4-Cl2-Ph- 
5 e 3-Br-Ph-CHO 3-Br-Ph- 
6 f 4-Br-Ph-CHO 4-Br-Ph- 
7 g 4-F-Ph-CHO 4-F-Ph- 
8 h 3-NO2-Ph-CHO 3-NO2-Ph- 
9 i 4-NO2-Ph-CHO 4-NO2-Ph- 
10 j 4-CH3-Ph-CHO 4-CH3-Ph- 
11 k 3-CH3-Ph-CHO 3-CH3-Ph- 
12 l 2-CH3-Ph-CHO 2-CH3-Ph- 
13 m 3-OCH3,4-OH-Ph-CHO 3-OCH3,4-OH-Ph- 
14 n 3,4,5-(OCH3)3-Ph-CHO 3,4,5-(OCH3)3-Ph- 
Scheme 2 One-pot three component synthesis of 
2H-indazolo[1,2-b]phthalazine-triones in the presence of 
B(HSO4)3 under solvent-free conditions at 100 oC. 
 
RESULTS AND DISCUSSION 
At first B(HSO4)3 was prepared via the reaction of 
chlorosulfonic acid and boric acid[35]. One of the informative 
techniques for the investigation of the catalyst formation is 
FT-IR spectroscopy. So, the structure of catalyst was 
characterized by FT-IR spectroscopy (Fig. 1). As seen in Fig. 1 
the spectrum of B(HSO4)3 is different from that of boric acid. 
The FT-IR spectrum of B(HSO4)3 shows absorption bands at 
1400 (υ S=O asymmetric stretching), 1200  (υ S=O symmetric 
stretching) and  650 cm-1 corresponding to υ S-O. Moreover a 
broad band from 3400-2700 cm-1 corresponding to acidic O-H 
stretching. 
 
Fig. 1 IR spectra of B(HSO4)3 (a) and B(OH)3 (b) 
As we continued in order to optimize the reaction conditions, 
the one-pot three component condensation reaction between 
benzaldehyde (1.2 mmol), dimedone (1 mmol) and 
phthalhydrazide (1 mmol) was chosen as a model reaction. 
(Scheme 3) 
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Scheme 3 Condensation reaction of benzaldehyde , dimedone 
and phthalhydrazide 
At first, the influence of various amounts of catalyst on the 
reaction time and obtained yields were studied (Table І). We 
found that 75%  yield of 4a was obtained when 0.7 mole % 
catalyst was used. This yield increased to 92 % as B(HSO4)3 
loading went up to 5.3 mole % (entries, 1 and 4). 5.3 mole % of 
catalyst was sufficient and excess B(HSO4)3 did not increase 
the yield substantially(entries, 5 and 6).  
 
Table 1 influence of different amount of catalyst ( B(HSO4)3; 
mole % ) on the one-pot three component reaction between 
benzaldehyde (1.2 mmol), dimedone (1 mmol) and 
phthalhydrazide (1 mmol) under solvent-free condition at 100 
oC. 
Entry 
amount of 
catalyst, 
mole % 
T / oC t / min Yield, %a 
1 0.7 100 31 75 
2 2.6 100 17 77 
3 4 100 12 86 
4 5.3 100 12 92 
5 6.5 100 11 88 
6 8 100 11 87 
   a Yields refer to the isolated pure products. 
 
It is indisputable that temperature is a crucial factor for organic 
reactions, so we examined the reaction in the various 
temperatures (Table ІІ). The best result was obtained at 100 oC 
(entry 2). 
Table 2 Effect of temperature on the yield of reaction between 
benzaldehyde (1.2 mmol), dimedone (1 mmol), 
phthalhydrazide (1 mmol) and catalyst ( B(HSO4)3; 5.3 mole 
%) under solvent-free condition. 
Entry T / oC t / min Yield, %a 
1 120 12 92 
2 100 12 92 
3 80 12 83 
       a isolated Yields refer to the pure products. 
Therefore, we kept the reaction temperature as 100 oC and 
amount of catalyst; 5.3 mole%. (giving proper reaction time 
and high yield). In order to establish the crucial role of 
B(HSO4)3 as a catalyst for the synthesis of titled compounds, 
 J. of Bioprocessing and Chemical Engineering               Volume 2 / Issue 2                                              ISSN: 2348 –3768 3 
the model reaction was examined without catalyst under 
optimized temperature and it was found that negligible 
conversion to desired product occurred even after 1 h of 
heating. 
In order to establish the generality and efficiency of our 
presented methodology for the synthesis of 2H-indazolo[1,2-b] 
phthalazine-triones, a broad range of aromatic aldehydes 
(3a-n) were condensed with phthalhydrazide (1) and dimedone 
(2) under optimized conditions. The results of reaction are 
summarized in Table ІІІ. In all cases, the reactions gave the 
corresponding products in good yield. This protocol tolerates a 
variety of aromatic aldehydes containing both 
electron-withdrawing and electron-donating substituents. As it 
is clear from Table ІІІ, substituents on the aromatic ring had no 
obvious effect on yields or reaction times under the above 
optimal conditions. The reactions are clean, efficient and swift 
and is accomplished with a simple procedure. 
 
Table 3 Solvent-free one-pot three component synthesis of 2H- indazolo[1,2-b]phthalazine-trione  derivatives in the presence of 
B(HSO4)3  as a catalyst at 100 oC. 
 
m.p. / oC (Lit.) Yield, %a T / min Product Aldehyde Entry 
206-207 (204-206)15 92  12 4a 3a 1 
261-262 (262-264)15 93 11 4b 3b 2 
204-205 (204-206)33d 84 17 4c 3c 3 
218-220 (219-221)33d 92 9 4d 3d 4 
224-225 (224-226)31 81 14 4e 3e 5 
260-262 (258-267)15,33d 89 12 4f 3f 6 
222-221 (217-226)15,33d 82 13 4g 3g 7 
271-272 (270-272)15 87 13 4h 3h 8 
220-222 (223-225)15 94 10 4i 3i 9 
226-227 (226-228)33d 81 18 4j 3j 10 
231-232 (232-233)31 82 17 4k 3k 11 
240-241 (241-243)33d 79 21 4l 3l 12 
250-251 (250-252)33d 94 14 4m 3m 13 
231-233 (232-234)33d 93 11 4n 3n 14 
                  aYields refer to pure isolated products. 
 
 
The catalyst recovery and reuse was evaluated taking the 
one-pot three component condensation reaction of 
benzaldehyde as a model reaction (scheme 3). After the 
reaction was completed, the crude products were dissolved in 
hot ethanol and insoluble catalyst was isolated by simple 
filtration. Then it was reused after washing with hot ethanol. 
Recovered catalyst showed the same activity as fresh catalyst 
(Table ІV). In continuation of work up, the filtrate was 
concentrated under reduced pressure. Then obtained crude 
products were recrystalized from EtOH/H2O 3:1. 
 
Table 4 Evaluation of The catalyst reusability in one-pot three 
component reaction between benzaldehyde (1.2 mmol), 
dimedone (1 mmol), phthalhydrazide (1 mmol) and catalyst ( 
B(HSO4)3; 5.3 mole %) under solvent-free condition at 100 oC. 
 
 
No. of cycles t / min Yield, %a 
Fresh catalyst 12 92 
1 12 92 
2 12 91 
3 12 89 
4 12 88 
5 12 86 
  a Yields refer to the isolated pure products. 
 
A possible mechanism for the formation of (4a-n) is proposed 
in Scheme 4. It is reasonable to assume that (4a-n) results from 
initial formation of a heterodiene (5) by standard Knoevenagel 
condensation of the dimedone (2) and aldehyde (3). Then, the 
subsequent Michael-type addition of the phthalhydrazide (1) to 
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the heterodyne (5) followed by cyclization affords the 
corresponding products (4) (Scheme 4). 
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Scheme 4 Proposed mechanism for the synthesis of 
2H-indazolo[1,2-b]phthalazine-triones via a one-pot three 
component condensation reaction between phthalhydrazide, 
dimedone and aldehydes. 
 
The results were good in terms of yields and product purity. 
The nature of these compounds are 1:1:1 adducts. This was 
apparent by mass spectroscopy. In each case, mass spectrum 
was shown the molecular ion peak at appropriate m/z values. 
All compounds (4a-n) are known and stable solids. Their 
physical and spectroscopic data were matched with those of 
authentic samples. The products were characterized by IR, 1H, 
and 13C NMR spectral data, mass spectrometry, and elemental 
analysis.  
In order to show the merits and accessibility of the present work 
in comparison with reported results in the literature, we 
compared some of the results of our present methodology with 
the reported methods for the one-pot three component synthesis 
of  2H-indazolo[1,2-b] phthalazine-trione derivatives (Table 
V). As shown in Table 5, boron sulfonic acid (BSA) can act as 
an effective catalyst with respect to reaction kinetic, 
inexpensive protocol and broad applicability in terms of yield. 
 
  
Table 5 Comparison of B(HSO4)3 with reported catalysts for the reaction of benzaldehyde, dimedone and phthalhydrazide. 
 
Reaction conditions Catalyst load, mol% t / min 
Yield, 
%a Ref. 
p-Toluenesulfonic acid/solvent-free/80 oC 30 10 86 15 
H2SO4/[bmim][BF4]/80 oC 15 30 86 16 
Poly phosphoric acid-SiO2/solvent-free/100 oC 5 8 92 33d 
SiWA/solvent-free/100 oC 1 16 92 31 
N,N,N´,N´-tetrabromobenzene-1,3-disulfonamide 
[TBBDA]/solvent-free/100 oC 1 10 89 21 
prolinetriflate/solvent-free/80oC 10 180 92 23 
(S)-camphorsulfonic acid/solvent-free/80oC 20 15 90 24 
Phosphomolybdic acid (PMA) – SiO2/solvent-free/80 oC 5 30 85 25 
B(HSO4)3/solvent-free/100 oC 5.3 12 92 This work 
a isolated pure Yields. 
 
EXPERIMENTAL SECTION 
All reagents were used as received without further purification. 
All yields refer to isolated products after purification. 
B(HSO4)3 was prepared according to the reported 
procedure[35]. Products were characterized by comparison of 
spectroscopic data (IR, 1H NMR, 13C NMR spectra) and 
melting points with authentic samples. Elemental analyses for 
C, H, and N were performed using a CHN-O-Rapid analyzer. 
The NMR spectra were recorded on a DPX 300- MHz 
instrument. The spectra were measured in CDCl3 relative to 
TMS (0.00 ppm). IR spectra were recorded on a RXi FT-IR 
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spectrophotometer. All of the compounds were solid and solid 
state IR spectra were recorded using the KBr disk technique. 
Mass spectra were recorded on an technologies 5973 network 
mass selective detector (MSD) operating at an ionization 
potential of 70 eV. Melting points were determined in open 
capillaries with melting point apparatus.  
Preparation of boron sulfonic acid 
A 50 mL kitasato flask was equipped with a constant pressure 
dropping funnel. The gas outlet was connected to a vacuum 
system through an adsorbing solution (water) and an alkali trap. 
Boric acid (1.55 g, 25 mmol) was charged in the flask and 
chlorosulfonic acid (8.74 g, ca. 5 mL, 75 mmol) was added 
drop wise over a period of 1 h at room temperature. HCl 
evolved immediately. After completion of the addition, the 
mixture was shaken for 1 h, while the residual HCl was 
eliminated by suction. Then the mixture was washed with 
diethyl ether to remove the unreacted chlorosulfonic acid. 
Finally, a grayish solid material was obtained in 89% yield (6.7 
g) . 
Typical procedure for the preparation of 
3,4-dihydro-3,3-dimethyl-13-phenyl-2H-indazolo[ 
1,2-b]phthalazine-1,6,11(13H)-trione (4a) 
To a mixture of benzaldehyde (1.2 mmol), phthalhydrazide (1 
mmol) and dimedone (1 mmol), B(HSO4)3 ( 5.3 mmol % ) was 
added and the mixture was stirred at 100oC for appropriate time 
(Table 4). Completion of the reaction was followed by TLC. 
After the completion of the reaction, ethanol was added and the 
reaction mixture was heated until solid crude product was 
dissolved. Then, the heterogeneous catalyst was isolated by 
simple filtration and after washing with ethanol reused for other 
reactions. In continuation of work up, the filtrate was 
concentrated under reduced pressure. The crude products were 
recrystalized from EtOH/H2O 3:1 to afford the pure product 
(4a)(0.34g, 92%) as a yellow powder. 
M.p.: 206-207 oC(204-206 oC)15; IR (KBr) (v, cm-1): 2959, 
1661, 1618, 1469, 1421, 1358, 1302, 1273, 1141, 1074, 749, 
691; 1H NMR (300 MHz, CDCl3): δ = 1.21 (s, 6H), 2.33 (s, 
2H), 3.21-3.45 (AB system, J = 19.0 Hz, 2H), 6.45 (s, 1H), 
7.27-7.40 (m, 5H), 7.85 (m, 2H), 8.27-8.35 (m, 2H) ppm; 13C 
NMR (75 MHz, CDCl3): δ = 28.4, 28.6, 34.5, 38.0, 50.9, 64.9, 
118.5, 127.0, 127.6, 127.9, 128.61, 12864, 128.9, 129.0, 133.4, 
134.4, 136.3, 150.7, 154.2, 155.9, 192.0 ppm; MS, m/z (%) = 
372 (M+, 21), 295 (100), 104 (67), 76 (53). Anal. Calcd for 
C23H20N2O3: C, 74.18; H, 5.41; N, 7.52%. Found: C, 74.23; H, 
5.39; N, 7.48%.  
 
3,4-Dihydro-3,3-dimethyl-13-(4-chlorophenyl)-2H-indazolo[1
,2-b]phthalazine-1,6,11(13H)-trione (4b) 
White powder (93%); M.p.: 261-262 oC (262-264 oC)15; IR 
(KBr) (v, cm-1): 2957, 1662, 1624, 1469, 1393, 1352, 1312, 
1268, 1149, 827, 745; 1H NMR (300 MHz, CDCl3): δ = 1.20 (s, 
6H), 2.33 (s, 2H), 3.20-3.43 (AB system, J = 19.1 Hz, 2H), 6.40 
(s, 1H), 7.28-7.37 (m, 4H), 7.85 (m, 2H), 8.25-8.34 (m, 2H) 
ppm; 13C NMR (75 MHz, CDCl3): δ = 28.4, 28.6, 34.5, 37.9, 
50.8, 64.2, 115.5, 115.8, 118.1, 127.6, 127.9, 128.8, 128.91, 
128.95, 128.99, 132.1, 132.2, 133.5, 134.5, 150.9, 154.3, 
155.9, 192.0 ppm; MS, m/z (%) = 406 (M+ , 8), 295 (100), 104 
(39), 76 (22); Anal. Calcd for C23H19ClN2O3: C, 67.90; H, 4.71; 
N, 6.89%. Found: C, 67.84; H, 4.63; N, 6.81%. 
3,4-Dihydro-3,3-dimethyl-13-(3-chlorophenyl)-2H-indazolo[1
,2-b]phthalazine-1,6,11(13H)-trione (4c). 
Yellow powder (84%); M.p.: 204-205 oC (204-206 oC)33d; IR 
(KBr) (v, cm-1) ; 2957, 2872, 1649, 1626, 1578, 1467, 1360, 
1315, 1268, 1147, 791, 701;  1H NMR (300 MHz, CDCl3): δ = 
1.21 (s, 6H), 1.22 (s, 3H), 2.35(s, 2H), 3.22-3.41 (AB system, J 
= 19.1 Hz, 2H), 6.39 (s, 1H), 7.22-8.40 (m, 8H), ppm; 13C NMR 
(75 MHz, CDCl3): δ = 28.5, 28.6, 34.6, 37.9, 50.9, 64.4, 118.0, 
125.8, 126.9, 127.7, 128.1, 128.9, 129.0, 130.0, 133.7, 134.6, 
138.5, 151.2, 154.5, 155.9, 192.1 ppm; MS: m/z (%) = 406 (M+, 
21), 295 (100), 104 (31), 76 (27). ), Anal. Calcd for 
C23H19ClN2O3: C, 67.90; H, 4.71; N, 6.89%.Found: C, 67.88; 
H, 4.72; N, 6.87 %. 
 
3,4-Dihydro-3,3-dimethyl-13-(2,4-Dichlorophenyl)-2H-indazo
lo[1,2-b]phthalazine-1,6,11(13H)-trione (4d).  
Yellow powder (92%); M.p.: 218-220 oC (219-221oC)15; IR 
(KBr) (v, cm-1): 2964, 1660, 1628, 1468, 1391,1351, 1312, 
1267, 1146, 1101, 832, 701  1H NMR (300 MHz, CDCl3): δ = 
1.22 (s, 3H), 1.23(s, 3H), 2.34 (s, 2H), 3.25-3.40 (AB system, J 
= 19.1 Hz, 2H), 6.59 (s, 1H), 7.26-8.37(m, 8H), ppm; 13C NMR 
(75 MHz, CDCl3): δ = 28.5, 28.8, 34.6, 38.1, 50.8, 63.6, 127.7, 
127.8, 128.1, 128.6, 129.1, 130.8, 131.8, 133.4,133.8, 134.6, 
134.9, 152.1, 154.3, 156.1, 192.2 ppm; MS, m/z (%) = 441 (M+, 
4),295(100), 104 (37), 76 (23), Anal. Calcd for C23H18Cl2N2O3: 
C, 62.59; H, 4.12; N, 6.35%.Found: C, 62.56; H, 4.10; N, 6.26 
%. 
 
3,4-Dihydro-3,3-dimethyl-13-(3-bromophenyl)-2H-indazolo[1
,2-b]phthalazine-1,6,11(13H)-trione (4e) 
Yellow powder (81%), M.p.: 224-225 oC(224-226 oC)31; IR 
(KBr) (v, cm-1): 2981, 1622, 1448, 1419, 1361, 1312, 1267, 
1123, 1056, 948, 861; 1HNMR (300 MHz, CDCl3): δ = 1.20 (s, 
3H), 1.21 (s, 3H), 2.34 (s, 2H), 3.23-3.41 (AB system, J = 19.1 
Hz, 2H), 6.38 (s, 1H), 7.28-8.38 (m, 8H) ppm; 13CNMR (75 
MHz, CDCl3): δ  = 28.4, 28.7, 34.5, 38.1, 50.9, 64.1, 116.7, 
122.7, 126.4, 127.6, 127.9, 129.1, 129.7, 130.4, 131.9, 133.5, 
134.6, 138.6, 151.2, 154.3, 155.9, 191.8 ppm; MS, m/z (%) = 
451 (M+, 7), 295(100), 104(28), 76(34). Anal. Calcd for 
C23H19BrN2O3: C, 61.21; H, 4.17; N, 6.21%. Found: C, 61.14; 
H, 4.17; N, 6.30 %. 
 
3,4-Dihydro-3,3-dimethyl-13-(4-bromophenyl)-2H-indazolo[1
,2-b]phthalazine-1,6,11(13H)-trione (4f) 
White powder (89%); M.p.: 260-262 oC (258-267 oC)15, 33d; IR 
(KBr) (v, cm-1): 2959, 1655, 1623, 1469, 1388, 1360, 1309, 
1267, 1141, 843, 769; 1H NMR (300 MHz, CDCl3): δ = 1.20 (s, 
6H), 2.33 (s, 2H), 3.20-3.44 (AB system, J = 19.1 Hz, 2H), 6.40 
(s, 1H), 7.28-7.37 (m, 4H), 7.85 (m, 2H), 8.25-8.34 (m, 2H) 
ppm; 13C NMR (75 MHz, CDCl3): δ = 28.4, 28.6, 34.5, 37.9, 
50.8, 64.2, 115.5, 115.8, 118.1, 127.6, 127.9, 128.8, 128.91, 
128.95, 128.99, 132.1, 132.2, 133.5, 134.5, 150.9, 154.3, 
155.9, 192.0 ppm; MS, m/z (%) = 451 (M+ , 11), 295 (100), 104 
(32), 76 (43); Anal. Calcd for C23H19BrN2O3: C, 61.21; H, 4.17; 
N, 6.21%. Found: C, 61.19; H, 4.27; N, 6.18%. 
 
3,4-Dihydro-3,3-dimethyl-13-(4-fluorophenyl)-2H-indazolo[1,
2-b]phthalazine-1,6,11(13H)-trione (4g) 
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Yellow powder (82%); M.p.: 221-223 oC (217-226 oC)15, 33d; IR 
(KBr) (v, cm-1): 2958, 2880, 1664, 1626, 1517, 1468, 1369, 
1312, 1263, 1219, 1024, 843, 791; 1H NMR (300 MHz, 
CDCl3): δ = 1.21 (s, 6H), 2.34 (s, 2H), 3.27-3.38 (AB system, J 
= 19.0 Hz, 2H), 6.43 (s, 1H), 7.02 (m, 2H), 7.40 (m, 2H), 7.85 
(m, 2H), 8.27-8.34 (m, 2H) ppm; 13C NMR (75 MHz, CDCl3): δ 
= 28.4, 28.6, 34.6, 37.9, 50.8, 64.2, 115.5, 115.8, 118.1, 127.6, 
127.9, 128.8, 128.93, 128.99, 132.1, 132.2, 133.5, 134.5, 
150.9, 154.3, 155.9, 192.1 ppm; MS, m/z (%) = 390 (M+ , 12), 
295 (100), 104 (58), 76 (8). Anal. Calcd for C23H19FN2O3: C, 
70.76; H, 4.91; N, 7.18%. Found: C, 70.62; H, 4.99; N, 7.11%. 
 
3,4-Dihydro-3,3-dimethyl-13-(3-nitrophenyl)-2H-indazolo[1,2
-b]phthalazine-1,6,11(13H)-trione (4h) 
Yellow powder (87%); M.p.: 271-272 oC (270-272 oC)15; IR 
(KBr) (v, cm-1): 2945, 1683, 1672, 1615, 1358, 1273, 1152, 
1104, 749; 1H NMR (300 MHz, CDCl3): δ = 1.22 (s, 6H), 2.35 
(s, 2H), 3.47-3.24 (AB system, J =19.2 Hz, 2H), 6.52 (s, 1H), 
7.53-8.39 (m, 8H) ppm; 13C NMR (75 MHz, CDCl3): δ = 28.3, 
28.9, 34.6, 38.3, 51.6, 64.2, 116.8, 127.3, 127.3, 128.4, 128.8, 
129.2, 129.8, 131.5, 132.8, 133.1, 133.6, 134.5, 135.4, 151.8, 
154.4, 156.3, 192.2; MS, m/z (%) = 417 (M+ , 12), 295 (100), 
104 (49), 76 (79). Anal. Calcd for C23H19N3O5 : C, 66.18; N, 
10.07; H, 4.59%. Found: C, 66.15; N, 10.23; H, 4.61%. 
 
3,4-Dihydro-3,3-dimethyl-13-(4-nitrophenyl)-2H-indazolo[1,2
-b]phthalazine-1,6,11(13H)-trione (4i) 
Yellow powder (94%); M.p.: 220-222 oC (223-225 oC)15; IR 
(KBr) (v, cm-1): 2943, 1695, 1659, 1616, 1519, 1359, 1276, 
1170, 1109,861,793; 1H NMR (300 MHz, CDCl3): δ = 1.19 (s, 
3H), 1.22 (s, 3H), 2.34 (s, 2H), 3.22-3.44 (2H, AB system, J = 
18.99 Hz, 2H), 6.51 (s, 1H), 7.59-7.89 (m, 4H), 8.19-8.37 (m, 
4H) ppm; 13C NMR (75 MHz, CDCl3): δ = 28.2, 28.6, 34.6, 
37.9, 50.7, 64.0, 117.2, 123.8, 123.9, 127.6, 128.0, 128.1, 
128.5, 128.6, 128.8, 133.8, 134.7, 143.4, 147.8, 151.6, 154.5, 
155.8, 191.9; MS, m/z (%) = 417 (M +, 6), 295 (100), 104 (46), 
76 (69). Anal. Calcd for C23H19N3O5: C, 66.18; H, 4.59; N, 
10.07%. Found: C, 66.21; H, 4.68; N, 9.99%. 
 
3,4-Dihydro-3,3-dimethyl-13-(4-methylphenyl)-2H-indazolo[1
,2-b]phthalazine-1,6,11(13H)-trione (4j) 
Yellow powder (81%); M.p.: 226-227 oC (226-228 oC)33d; IR 
(KBr) (v, cm-1): 2956, 1663, 1627, 1463, 1360, 1312, 1269, 
1080, 1024,829, 789; 1H NMR (300 MHz, CDCl3): δ = 1.21 (s, 
6H), 2.29 (s, 3H), 2.33 (s, 2H), 3.20-3.45(AB system, J = 19.0 
Hz, 2H), 6.42 (s, 1H), 7.12-7.15 (m, 2H), 7.29-7.31 (m, 2H), 
7.84 (m, 2H), 8.27-8.35 (m, 2H) ppm; 13C NMR (75 MHz, 
CDCl3): δ = 21.1, 28.4, 28.6, 34.5, 38.0, 50.9, 64.7, 118.6, 
127.0, 127.6, 127.8, 128.9, 129.1, 129.3, 133.3, 134.3, 138.4, 
150.6, 154.1, 155.9, 192.0 ppm; MS, m/z (%) = 386 (M +, 9), 
295 (100), 104 (43), 76 (42). Anal. Calcd for C24H22N2O3: C, 
74.59; H, 5.74; N, 7.25% Found: C, 74.51; H, 5.75; N, 7.29 %. 
 
3,4-Dihydro-3,3-dimethyl-13-(3-methylphenyl)-2H-indazolo[1
,2-b]phthalazine-1,6,11(13H)-trione(4k) 
Yellow powder(82%), M.p.: 231-232 oC (232-233 oC)31; IR 
(KBr) (v, cm-1): 2958, 1639, 1660,1610, 1428, 1356, 1315, 
1271, 1120, 1076, 941, 853; 1H NMR (300 MHz, CDCl3): δ  = 
1.20 (s, 3H), 1.21 (s, 3H), 2.31 (s, 3H), 2.32 (s, 2H), 3.24-3.44 
(AB system, J = 18.9 Hz, 2H), 6.41 (s, 1H), 7.08 (d, J = 7.5 Hz, 
1H), 7.18-7.23 (m, 3H), 7.83-7.87 (m, 2H), 8.26–8.30 (m, 1H), 
7.05-8.38 (m, 8H) ppm; 13C NMR (75 MHz, CDCl3): δ  = 20.9, 
28.5, 28.8, 34.9, 38.1, 51.0, 64.8, 119.0, 124.4, 127.2, 127.9, 
128.1, 128.6, 129.1, 129.3, 129.6, 133.1, 134.4, 136.3, 138.4, 
150.7, 154.0, 156.1, 192.2 ppm; MS: m/z (%) = 386 (M+, 14), 
295 (100),104 (23), 76 (36). Anal. Calcd for C24H22N2O3: C, 
74.59; H, 5.74; N, 7.25%. Found: C, 74.57; H, 6.76; N, 7.21 %. 
 
3,4-Dihydro-3,3-dimethyl-13-(2-methylphenyl)-2H-indazolo[1
,2-b]phthalazine 1,6,11(13H)-trione (4l).  
Yellow powder (79%); M.p.: 240-241 oC (241-243 oC)33d; IR 
(KBr) (v, cm-1): 2949, 1662, 1603, 1439,1359, 1315, 1275, 
1149, 1080, 864, 799; 1H NMR (300 MHz, CDCl3): δ = 1.20 (s, 
3H), 1.22 (s, 3H), 2.31(s, 3H), 2.33 (s, 2H), 3.24-3.42 (AB 
system, J = 19.0 Hz, 2H), 6.39 (s, 1H), 7.09- 8.32 (m, 8H) ppm; 
13C NMR (75 MHz, CDCl3): δ = 19.9, 28.3, 28.8, 34.7, 38.1, 
50.9, 64.3, 119.1, 124.1, 127.4, 127.6, 128.0, 128.4, 129.0, 
129.2, 129.8, 133.5, 134.5, 136.3, 138.1, 150.6, 154.2, 156.0, 
192.1 ppm; MS: m/z (%) = 386 (M+, 12), 295 (100), Anal. 
Calcd for C24H22N2O3: C, 74.59; H, 5.74; N, 7.25% Found: C, 
74.55; H, 5.76; N, 7.26 %. 
 
3,4-Dihydro-3,3-dimethyl-13-(4-Hydroxy-3-methoxyphenyl)-2
H-indazolo[1,2-b]phthalazine-1,6,11(13H)-trione (4m). 
Yellow powder (94%); M.p.: 250-251 oC (250-252 oC)33d; IR 
(KBr) (v, cm-1): 2958, 1661, 1600, 1489, 1362, 1270, 1229, 
1135, 1031, 790, 647: 1H NMR (300 MHz, CDCl3): δ=1.22 (s, 
6H), 1.23(s, 3H), 2.35 (s, 2H), 3.23-3.46 (AB system, J = 19.0 
Hz, 2H), 3.91 (s, 3H),5.32-5.34 (br, 1H), 6.40 (s, 1H), 
6.77-7.10 (m, 3H), 7.87-8.41 (m,4H) ppm; 13C NMR (75MHz, 
CDCl3): δ = 28.4, 28.8, 34.7, 38.1, 51.1, 56.3, 64.8, 110.9, 
114.6, 118.6, 119.3, 127.8, 128.0,128.2, 129.0, 129.3, 133.4, 
134.5, 145.9, 146.4, 150.7, 156.0, 192.2 ppm; MS: m/z (%) = 
418 (M+, 11), 295(100), 104(92), 76(46); 295 (100),104 (92), 
76 (46). Anal. Calcd for C24H22N2O5: C, 68.89; H, 5.30; N, 
6.69%. Found: C, 68.86; H, 5.31; N, 6.73%. 
 
3,3-Dimethyl-13-(3,4,5-trimethoxyphenyl)-3,4-dihydro-2H-ind
azolo[1,2-b]phthalazine- 1, 6,11(13H)-trione (4n).  
Yellow powder (93%); M.p.: 231-233 oC (232-234 oC)33d; IR 
(KBr) (v, cm-1): 2960, 1656, 1632, 1601,1466, 1432, 1361, 
1313, 1268, 1125, 989, 704; 1H NMR (300 MHz, CDCl3): δ = 
1.22 (s, 3H), 1.24 (s, 3H), 2.36 (s, 2H), 3.21 (d, J = 19.1 Hz, 
1H), 3.47 (AB system, J = 19.2 Hz, 2H), 3.79 (s, 3H), 3.82 (s, 
6H), 6.41 (s, 1H), 6.62 (s, 1H), 7.81-8.37 (m, 4H) ppm; 13C 
NMR (75 MHz, CDCl3): δ = 28.1, 29.0, 34.5, 38.1, 51.1, 56.2, 
60.8, 65.1, 104.6, 118.4, 127.7, 128.1, 130.0, 129.0, 131.8, 
133.7, 134.6, 138.3, 150.9, 153.5, 154.6, 156.1, 192.2 ppm; 
MS: m/z (%) = 462 (M+, 34), 295 (100),104 (9), 76 (8). Anal. 
Calcd for C26H26N2O6: C, 67.52; H, 5.67; N, 6.06% Found: C, 
67.43; H, 5.67; N, 6.11. %. 
 
CONCLUSIONS 
In summary, an efficient protocol for the preparation of 
2H-indazolo[1,2-b] phthalazine-trione derivatives via one-pot 
three-component condensation reaction between 
phthalhydrazide, dimedone and aldehydes using B(HSO4)3  as 
an efficient and reusable catalyst was described. The reactions 
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were completed under thermal solvent-free conditions in short 
times and produced the corresponding products in good yields. 
The one-pot nature and the use of a heterogeneous solid acid as 
an eco-friendly catalyst make it an interesting alternative 
method  in terms of 2H-indazolo[1,2-b] phthalazine- triones 
synthesis. 
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